Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a massive Real-World registry make vascular access safer?

NCT ID NCT06604039

Knowledge-focused Sponsor: Teleflex Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study is a large registry that will follow about 2,500 people who receive a Teleflex vascular access device—such as a central venous catheter, dialysis catheter, or peripheral IV—during their medical care. The goal is to collect real-world data on how well these devices work and how safe they are in everyday hospital settings. Researchers will track successful device use without complications and any device-related adverse events. The findings could help improve the safety and effectiveness of these common medical tools.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Teleflex vascular access devices (central venous catheters, dialysis catheters, midline IV catheters, peripheral IV catheters, arterial catheters, and catheter navigation/tip confirmation devices)
What this could lead to
If successful, this registry could provide real-world evidence on the safety and performance of these devices, potentially guiding better clinical practices and device improvements.
What could go wrong
As an observational registry, it cannot prove cause and effect, and results may be influenced by variations in real-world use and patient populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Dec 2034

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects who are scheduled to receive a vascular access procedure using at least one Teleflex vascular access device will be considered for enrollment.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects will undergo a procedure that will include use of a Teleflex device covered by this Research. * Subject is willing and capable of providing informed consent and/or give approval to collect, store and process limited health information by the Sponsor; or such consent is provided by a legally designated representative if required by local law or regulation. * Subjects is able to read and understand English or Spanish languages Exclusion Criteria: * Subject is currently participating in another clinical Registry or investigation that may confound the results of this Registry. * Subject was previously failed screening or was enrolled in this clinical Registry. * Subject is imprisoned * Subject is cognitively impaired and unable to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Vascular access device are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Vascular access device

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Huntsville Hospital

    RECRUITING

    Huntsville, Alabama, 35801, United States

  • Loma Linda University Health

    RECRUITING

    Loma Linda, California, 92354, United States

  • Tufts Medical Center

    RECRUITING

    Boston, Massachusetts, 02111, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.